120 related articles for article (PubMed ID: 7931160)
1. Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes.
Sample J; Kieff EF; Kieff ED
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2741-6. PubMed ID: 7931160
[TBL] [Abstract][Full Text] [Related]
2. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
Miller WE; Edwards RH; Walling DM; Raab-Traub N
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
[TBL] [Abstract][Full Text] [Related]
3. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene.
Busson P; Edwards RH; Tursz T; Raab-Traub N
J Gen Virol; 1995 Jan; 76 ( Pt 1)():139-45. PubMed ID: 7844523
[TBL] [Abstract][Full Text] [Related]
4. Sequence variations between two Epstein-Barr virus LMP 1 variants have no effect on the activation of NF-kappaB activity.
Yeh TS; Li SN; Wu CJ; Liu ST; Meng CL; Chang YS
DNA Cell Biol; 1997 Nov; 16(11):1311-9. PubMed ID: 9407003
[TBL] [Abstract][Full Text] [Related]
5. Unusually high frequency of a 69-bp deletion within the carboxy terminus of the LMP-1 oncogene of Epstein-Barr virus detected in Burkitt's lymphoma of Turkish children.
Tacyildiz N; Cavdar AO; Ertem U; Oksal A; Kutluay L; Uluoglu O; Lin JC
Leukemia; 1998 Nov; 12(11):1796-805. PubMed ID: 9823956
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China.
Sung NS; Edwards RH; Seillier-Moiseiwitsch F; Perkins AG; Zeng Y; Raab-Traub N
Int J Cancer; 1998 Apr; 76(2):207-15. PubMed ID: 9537582
[TBL] [Abstract][Full Text] [Related]
9. The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene.
Walling DM; Shebib N; Weaver SC; Nichols CM; Flaitz CM; Webster-Cyriaque J
J Infect Dis; 1999 Apr; 179(4):763-74. PubMed ID: 10068570
[TBL] [Abstract][Full Text] [Related]
10. [Sequence analysis of the carboxy terminal of the Epstein-Barr virus LMP-1 oncogene in Epstein-Barr virus associated disorders].
Itakura O; Kikuta H
Nihon Rinsho; 1997 Feb; 55(2):467-72. PubMed ID: 9046842
[TBL] [Abstract][Full Text] [Related]
11. [Internal deletions of the latent membrane protein oncogenes of Epstein-Barr virus in Hodgkin's disease are almost identical with those of Asiatic nasopharyngeal carcinoma].
Odermatt BF; Heitz PU; Bachmann E; Brousset P; Sandvej K; Knecht H
Verh Dtsch Ges Pathol; 1994; 78():324-8. PubMed ID: 7534006
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
Sample J; Young L; Martin B; Chatman T; Kieff E; Rickinson A; Kieff E
J Virol; 1990 Sep; 64(9):4084-92. PubMed ID: 2166806
[TBL] [Abstract][Full Text] [Related]
13. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
[TBL] [Abstract][Full Text] [Related]
14. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
[TBL] [Abstract][Full Text] [Related]
15. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
Evans TJ; Jacquemin MG; Farrell PJ
Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
[TBL] [Abstract][Full Text] [Related]
16. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations.
Lei H; Li T; Li B; Tsai S; Biggar RJ; Nkrumah F; Neequaye J; Gutierrez M; Epelman S; Mbulaiteye SM; Bhatia K; Lo SC
Sci Rep; 2015 Nov; 5():16706. PubMed ID: 26593963
[TBL] [Abstract][Full Text] [Related]
18. Differences in EBNA2 and LMP-1 carboxy terminal region sequences of Epstein-Barr virus type A between the tumors in a multiple cancer patient.
Higa M; Kinjo T; Miyagi J; Sakumoto N; Iwamasa T; Kishaba M; Sunakawa H
Pathol Res Pract; 2001; 197(6):401-9. PubMed ID: 11432667
[TBL] [Abstract][Full Text] [Related]
19. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.
Correa RM; Fellner MD; Alonio LV; Durand K; Teyssié AR; Picconi MA
J Med Virol; 2004 Aug; 73(4):583-8. PubMed ID: 15221903
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.
Chen ML; Tsai CN; Liang CL; Shu CH; Huang CR; Sulitzeanu D; Liu ST; Chang YS
Oncogene; 1992 Nov; 7(11):2131-40. PubMed ID: 1331932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
